Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 1,597 | 1,597 | 1,598 | 1,697 | 1,969 |
| Gross Profit | 1,597 | 1,597 | 1,598 | 1,697 | 1,969 |
| Operating Expenses | 15,562 | 12,708 | 12,512 | 132,939 | 14,009 |
| Operating Income | -13,965 | -11,111 | -10,914 | -131,242 | -12,040 |
| Other Income | -1,522 | -113 | 60 | 42 | 21 |
| Pre-tax Income | -15,487 | -11,224 | -10,854 | -131,200 | -12,019 |
| Net Income Continuous | -15,487 | -11,224 | -10,854 | -131,200 | -12,019 |
| Net Income | $-15,487 | $-11,224 | $-10,854 | $-131,200 | $-12,019 |
| EPS Basic Total Ops | -22.49 | -16.49 | -16.49 | -151.42 | -13.49 |
| EPS Basic Continuous Ops | -17.77 | -12.88 | -12.47 | -150.86 | -13.84 |
| EPS Diluted Total Ops | -22.49 | -16.49 | -16.49 | -151.42 | -13.49 |
| EPS Diluted Continuous Ops | -17.77 | -12.88 | -12.47 | -150.86 | -13.84 |
| EBITDA(a) | $-13,886 | $-11,048 | $-10,842 | $-131,159 | $-11,968 |